Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067834 · ClinicalTrials.gov registry record · Phase 1
Electromagnetic Treatment For Bone Loss After Forearm Fracture
A Phase 1 study, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
NCT00067834 is a Phase 1 study that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 80 participants.
The verdict
NCT00067834, a Phase 1 study, has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will determine the usefulness of pulsing electromagnetic field (PEMF) technology to reverse or reduce the bone loss (osteopenia) that occurs in the forearm after fracture or surgery.
Interventions
- DEVICE Pulsing electromagnetic field (PEMF)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2003-11 |
| Est. Completion | 2006-10 |
| Phase | Phase 1 |
Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)93 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067834
The ClinicalTrials.gov registry entry for NCT00067834 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulsing electromagnetic field (PEMF) is the first listed.
NCT00067834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067834 about?
NCT00067834 is a clinical study titled "Electromagnetic Treatment For Bone Loss After Forearm Fracture". This study will determine the usefulness of pulsing electromagnetic field (PEMF) technology to reverse or reduce the bone loss (osteopenia) that occurs in the forearm after fracture or surgery.
What is the current status of trial NCT00067834?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2003-11. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00067834?
The interventions under investigation include: Pulsing electromagnetic field (PEMF) (DEVICE).
Who is sponsoring clinical trial NCT00067834?
This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.